aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2025. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
The Pfizer Foundation, established by Pfizer Inc., a global pharmaceutical and biotechnology giant founded in 1849 by Charles Pfizer and Charles F. Erhart in New York City, is dedicated to funding programs that provide public benefit, advance medical care, and improve patient outcomes. The foundation's core mission is to ensure that all people have access to safe, effective, and affordable medicines, thereby enabling healthier lives. Pfizer Inc. offers a wide range of pharmaceutical drugs and vaccines, serving markets worldwide.
Notable figures associated with Pfizer include Albert Bourla, the CEO of Pfizer Inc. The foundation has made significant contributions to global health, particularly through its involvement in the development and distribution of the Pfizer-BioNTech COVID-19 vaccine. With a revenue of $58.5 billion in 2023, Pfizer's impact on public health is profound, providing essential healthcare products and advancing medical research globally. The foundation's efforts have been pivotal in improving patient outcomes and expanding access to critical medicines and vaccines.
Operating Status
Active
Ownership Type(s)
Private
Main Product(s)
Grants, Philanthropy
Technology
HealthTech
Model Types
Recurring
Customer Type(s)
Non-Profit
Geographic Exposure
Global
When was Pfizer Foundation founded?
Pfizer Foundation was founded in 1849.
Where is Pfizer Foundation’s headquarters located?
Pfizer Foundation’s headquarters is located in DE, US.
When was Pfizer Foundation’s last funding round?
Pfizer Foundation’s most recent funding round was for $31B (USD) in May 2023.
How many employees does Pfizer Foundation have?
Pfizer Foundation has 83000 employees as of Feb 6, 2024.
How much has Pfizer Foundation raised to-date?
As of July 05, 2023, Pfizer Foundation has raised a total of $31B (USD) since May 16, 2023.
Add Comparison
Total Raised to Date
$31B
USD
Last Update May 16, 2023
Last Deal Details
$31B
USD
May 16, 2023
Post Ipo Debt
Total Employees Over Time
83000
As of Feb 2024
Pfizer Foundation Address
Delaware
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts